Avita Medical
RCEL
48 hedge funds and large institutions have $22.8M invested in Avita Medical in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 16 closing their positions.
2,174% more call options, than puts
Call options by funds: $4.23M | Put options by funds: $186K
3.08% less ownership
Funds ownership: 20.31% → 17.22% (-3.1%)
6% less capital invested
Capital invested by funds: $24.2M → $22.8M (-$1.41M)
14% less funds holding
Funds holding: 56 → 48 (-8)
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
71% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$948K |
| 2 |
PVI
Pura Vida Investments
New York
|
+$723K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$304K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$207K |
| 5 |
Jane Street
New York
|
+$190K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.75M |
| 2 |
Renaissance Technologies
New York
|
-$548K |
| 3 |
Millennium Management
New York
|
-$537K |
| 4 |
RI
RTW Investments
New York
|
-$507K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$460K |
RCEL Hedge Fund Activity: Q3 2022 in Review
48 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q3 2022, worth a combined $22.8M — down 5.8% from $24.2M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of RCEL and 8 opened new positions — a net loss of 8 holders — while 17 trimmed existing stakes and 5 added.
The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $948K. The largest seller was Farallon Capital Management, exiting entirely with an estimated $2.75M sold.
- 48 institutional investors held Avita Medical (RCEL) as of Q3 2022, down from 56 in Q2 2022.
- Funds reported $22.8M of Avita Medical stock for Q3 2022, down 5.8% quarter-over-quarter.
- 8 funds opened new Avita Medical positions in Q3 2022 and 16 closed out, a net change of -8 holders.
- The largest Avita Medical buyer in Q3 2022 was Polar Asset Management Partners, an estimated $948K added.
- The largest Avita Medical seller in Q3 2022 was Farallon Capital Management, an estimated $2.75M sold.
Based on aggregated 13F filings for Q3 2022.